I am a board-certified medical oncologist and researcher specializing in the treatment of genitourinary cancers. My lab focuses on understanding the genetics and genetic epidemiology of prostate cancer, and the discovery of novel treatments for genitourinary cancers. As Chair of the Department of Medicine at Memorial Sloan Kettering, I oversee a department that is leading the development and testing of better cancer therapies. I look forward to seeing patients in the future as part of this role.
Before coming to MSK, I served as Director of the Lank Center for Genitourinary Oncology, Chief of the Division of Solid Tumor Oncology, Vice Chair of the Department of Medical Oncology, and Chair of the Executive Committee on Clinical Research at the Dana-Farber Cancer Institute. I am a professor of medicine at Harvard Medical School, the Chairman of the Global Treatment Science Network of the Prostate Cancer Foundation, and a member of numerous professional societies and editorial boards.
- Clinical Expertise: Prostate Cancer; Kidney Cancer; Bladder Cancer; Testicular Cancer
- Languages Spoken: English
- Education: MD, Brown University
- Residencies: New York University-Bellevue Hospital
- Fellowships: National Institutes of Health; Dana-Farber Cancer Institute
- Board Certifications: Internal Medicine; Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more